Strides Pharma Science Ltd.

NSE: STAR | BSE: 532531

Strong Performer

Download real time

1066.25 -2.75 (-0.26%)

New 52W High today

341.1K

NSE+BSE Volume

NSE 24 Apr, 2026 3:31 PM (IST)

Strides Pharma Corporate Filings & Announcements

Latest corporate announcements and filings from Strides Pharma on BSE

Search Inside the pdf :

Strides Pharma Science Ltd.

02 Apr 2026

1066.25

-0.26%

Company Update

Strides Pharma Science Ltd - 532531 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Certificate in terms of regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018, for the quarter ended March 31, 2026

Strides Pharma Science Ltd.

25 Mar 2026, 03:21PM

1066.25

-0.26%

SAST

Strides Pharma Science Ltd - 532531 - Closure of Trading Window

BSE India

Intimation regarding closure of Trading Window for the quarter and year ended March 31, 2026

Strides Pharma Science Ltd.

17 Mar 2026

1066.25

-0.26%

Company Update

Strides Pharma Science Ltd - 532531 - Disclosure Under Regulation 30 Of SEBI Listing Regulations

BSE India

This has reference to the Press Release issued by the Company today titled - Strides Strengthens its Africa Business with the Acquisition of Multiple Generic Brands from Sandoz. In this regard, please find enclosed herewith disclosure under Regulation 30 of SEBI Listing Regulations.

Strides Pharma Science Ltd.

17 Mar 2026

1066.25

-0.26%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Strides Strengthens its Africa Business with the Acquisition of Multiple Generic Brands from Sandoz

Strides Pharma Science Ltd.

17 Feb 2026

1066.25

-0.26%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

BSE India

Arco Lab Private Limited, a wholly owned subsidiary of the Company, has completed acquisition of Neviton Softech Private Limited

Strides Pharma Science Ltd.

05 Feb 2026

1066.25

-0.26%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release …

BSE India

Strides Pharma Inc receives USFDA closure report (EIR) for its formulations facility at Chestnut Ridge, New York Inspection included Drug Device Combinations covering our recent filing in Nasal Sprays domain

Strides Pharma Science Ltd.

05 Feb 2026

1066.25

-0.26%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Strides Pharma Inc receives USFDA closure report (EIR) for its formulations facility at Chestnut Ridge, New York Inspection included Drug Device Combinations covering our recent filing in Nasa Sprays domain

Strides Pharma Science Ltd.

04 Feb 2026

1066.25

-0.26%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Schedule of Analyst/ Institutional Investor''s Meet - Intimation under Regulation 30 of SEBI Listing Regulations

Strides Pharma Science Ltd.

03 Feb 2026

1066.25

-0.26%

Earnings Call

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.

Strides Pharma Science Ltd.

02 Feb 2026

1066.25

-0.26%

Company Update

Strides Pharma Science Ltd - 532531 - Response To Query Dated Feb 1, 2026 - Clarification …

BSE India

Response to BSE Query dated Feb 1, 2026 reference no. L/SURV/ONL/PV/APJ/2025-26/889

Is Strides Pharma Science Ltd. worth buying?

494 Votes:

Buy 78.95%

Sell 11.74%

Hold 9.31%

RESEARCH REPORTS

Buy SEE REPORTS >

Accumulate SEE REPORTS >